Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors

Academic Article
Publication Date:
2017
Short description:
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors / Aspeslagh, S., Shailubhai, K., Bahleda, R., Gazzah, A., Varga, A., Hollebecque, A., Massard, C., Spreafico, A., Reni, M., Soria, J.. - In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. - ISSN 0344-5704. - (2017).
Iris type:
1.1 Articolo in rivista
List of contributors:
Aspeslagh, S; Shailubhai, K; Bahleda, R; Gazzah, A; Varga, A; Hollebecque, A; Massard, C; Spreafico, A; Reni, M; Soria, J-C
Authors of the University:
RENI MICHELE
Handle:
https://iris.unisr.it/handle/20.500.11768/124042
Published in:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.6.0.0